KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 71 filers reported holding KALA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.94 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -83.3% | 3,916 | -16.2% | 0.00% | – |
| Q1 2022 | $6,000 | 0.0% | 4,675 | 0.0% | 0.00% | – |
| Q4 2021 | $6,000 | -97.3% | 4,675 | -94.4% | 0.00% | – |
| Q3 2021 | $220,000 | +185.7% | 83,957 | +478.6% | 0.00% | – |
| Q2 2021 | $77,000 | -20.6% | 14,511 | +0.6% | 0.00% | – |
| Q1 2021 | $97,000 | -3.0% | 14,426 | -1.9% | 0.00% | – |
| Q4 2020 | $100,000 | -9.9% | 14,706 | 0.0% | 0.00% | – |
| Q3 2020 | $111,000 | -35.5% | 14,706 | -10.2% | 0.00% | – |
| Q2 2020 | $172,000 | +473.3% | 16,376 | +388.0% | 0.00% | – |
| Q1 2020 | $30,000 | +76.5% | 3,356 | -26.5% | 0.00% | – |
| Q4 2019 | $17,000 | +6.2% | 4,566 | +10.0% | 0.00% | – |
| Q3 2019 | $16,000 | -40.7% | 4,151 | 0.0% | 0.00% | – |
| Q2 2019 | $27,000 | +17.4% | 4,151 | +50.6% | 0.00% | – |
| Q1 2019 | $23,000 | +130.0% | 2,757 | +41.0% | 0.00% | – |
| Q4 2018 | $10,000 | -47.4% | 1,956 | 0.0% | 0.00% | – |
| Q3 2018 | $19,000 | -29.6% | 1,956 | 0.0% | 0.00% | – |
| Q2 2018 | $27,000 | -32.5% | 1,956 | -21.9% | 0.00% | – |
| Q1 2018 | $40,000 | +14.3% | 2,506 | +35.7% | 0.00% | – |
| Q4 2017 | $35,000 | -18.6% | 1,847 | 0.0% | 0.00% | – |
| Q3 2017 | $43,000 | – | 1,847 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 771,790 | $5,788,000 | 5.46% |
| RA Capital Management | 10,874,613 | $81,560,000 | 1.49% |
| Mesirow Financial Investment Management, Inc. | 36,445 | $273,000 | 1.17% |
| Samsara BioCapital, LLC | 451,162 | $3,384,000 | 0.94% |
| Parkman Healthcare Partners LLC | 310,053 | $2,325,000 | 0.62% |
| Orbimed Advisors | 5,465,030 | $40,988,000 | 0.52% |
| Eventide Asset Management | 3,450,000 | $25,875,000 | 0.51% |
| Vivo Capital, LLC | 786,883 | $5,902,000 | 0.34% |
| Ikarian Capital, LLC | 451,531 | $3,387,000 | 0.24% |
| Matisse Capital | 50,300 | $377,000 | 0.15% |